Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003414
Status:
COMPLETED
Last Update Posted:
2015-07-20
First Post:
1999-11-01
Brief Title:
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkins Disease
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Graft Versus Host Disease |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| recurrent adult Hodgkin lymphoma | View |
| recurrent childhood lymphoblastic lymphoma | View |
| recurrentrefractory childhood Hodgkin lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent adult Burkitt lymphoma | View |
| graft versus host disease | View |
| recurrent childhood small noncleaved cell lymphoma | View |
| recurrent childhood large cell lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |